Type II Diabetes
Xigduo XR Receives Approval in China for the Treatment of Type II Diabetes in Adults
SG Tylor
Source – AstraZeneca On June 27, 2023, AstraZeneca’s Xigduo XR, a once-daily fixed-dose combination of dapagliflozin and metformin hydrochloride extended-release, ...
